01:29pm Thursday 14 December 2017

Pandemic vaccination did not increase risk of foetal death

This was found in a register study of women who were pregnant during the influenza pandemic in 2009. The study is published in the New England Journal of Medicine.

During the swine influenza pandemic, there were anecdotal reports of miscarriages and stillbirths occurring shortly after vaccination. Therefore, the Norwegian Institute of Public Health initiated a study to investigate if there was an association between pandemic influenza vaccination and foetal death.

Pregnant women are at increased risk of severe influenza infection. Previous studies have shown that pregnant women who were hospitalised with influenza had increased risk of foetal death. The researchers were interested in whether pandemic influenza also increased the risk of foetal death among pregnant women who were not admitted to hospital.

“Norway is one of very few countries that have the opportunity to study these issues because of our excellent health registers. The registers include information about pregnancy and pandemic vaccination,” says Dr. Camilla Stoltenberg, Director General of the Norwegian Institute of Public Health.

During the influenza A(H1N1) pandemic of 2009, the entire Norwegian population was offered the pandemic vaccine Pandemrix. Approximately 45 per cent were vaccinated. More than half (54 per cent) of those pregnant during the pandemic took the vaccine.

The study included more than 117,000 births in Norway occurring before, during and after the pandemic. Nearly 26,000 women were vaccinated against pandemic influenza while pregnant.

When analysing the data, the researchers took into account the timing of vaccination or influenza in pregnancy and the duration of each pregnancy.

 

Main findings 

  • Pregnant women who were vaccinated did not have increased risk of foetal death.
  • Pregnant women who were vaccinated had a considerably reduced risk of influenza. 
  • Pregnant women who were diagnosed with influenza during the pandemic had almost doubled risk of foetal death.

 

The Medical Birth Registry of Norway collects information about foetal death after week 12 of pregnancy, so the researchers could not examine early losses. Foetal death is rare in Norway (about 5 per 1000 births). Although this study found an increased risk after influenza, few pregnancies end in foetal death.

The results from this large study are in line with smaller studies from Denmark and Canada that also indicate that the pandemic vaccine was not associated with increased risk of foetal death.

“It is reassuring that such a large and comprehensive study did not find any evidence that vaccination increased the risk of foetal death,” says Dr. Stoltenberg. “The results suggest that influenza during pregnancy can be detrimental for the foetus, even if the mother is not seriously ill and admitted to hospital,” she adds.

 

Recommendations to pregnant women

“We recommend that pregnant women are vaccinated against influenza. In addition to protecting the mother, the vaccine protects the child in the first months after birth, at a time when the child is too young to be vaccinated,” says Dr. Stoltenberg.

Five of the researchers from NIPH

Five of the NIPH researchers who conducted the study, from left, Siri E. Håberg, Camilla Stoltenberg, Nina Gunnes, Lill Trogstad and Per Magnus.

The study was conducted by the Norwegian Institute of Public Health in collaboration with the Norwegian Medicines Agency and the National Institutes of Environmental Health Sciences in the USA. The authors of the article are Siri E. Håberg, Lill Trogstad, Nina Gunnes, Allen J. Wilcox, Håkon K. Gjessing, Sven Ove Samuelsen, Anders Skrondal, Inger Cappelen, Anders Engeland, Preben Aavitsland, Steinar Madsen, Ingebjørg Buajordet, Kari Furu, Per Nafstad, Stein Emil Vollset, Berit Feiring, Hanne Nøkleby, Per Magnus and Camilla Stoltenberg.

Reference

Håberg SE, et al. Risk of fetal death after pandemic influenza virus infection or vaccination. N Engl J Med 2013; 368:333-40. DOI: 10.1056/NEJMoa1207210.

  • Norwegian Institute of Public Health, PO Box 4404 Nydalen, N-0403 Oslo

Share on:
or:

MORE FROM Pregnancy and Childbirth

Health news